Pharmaceuticals by today's price change
How far the share price has moved since the previous close.
Summit Therapeutics leads the 61 pharmaceuticals ranked by today's price change, at +5.93%, ahead of Spyre Therapeutics (+2.31%) and ABIVAX (+2.27%). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Summit Therapeutics+5.93%
- Median
- +0.31%
- Combined market value
- NOK 49.72T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Summit TherapeuticsSMMT · Health Care | +5.93% | NOK 87.6B | NOK 109.57 | 5.93% up | 36% down | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +2.31% | NOK 88.4B | NOK 930.47 | 2.31% up | 286% up | ||
| 3 | ABIVAXABVX · Health Care | +2.27% | NOK 71.3B | NOK 813.99 | 2.27% up | 27% down | ||
| 4 | AlkermesALKS · Health Care | +1.99% | NOK 75.5B | NOK 449.38 | 1.99% up | 58% up | ||
| 5 | Legend BiotechLEGN · Health Care | +1.99% | NOK 30.9B | NOK 159.28 | 1.99% up | 42% down | ||
| 6 | TG TherapeuticsTGTX · Health Care | +1.96% | NOK 93.7B | NOK 619.86 | 1.96% up | 107% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | +1.92% | NOK 84.2B | NOK 3,014.09 | 1.92% up | 61% up | ||
| 8 | Amneal PharmaceuticalsAMRX · Health Care | +1.89% | NOK 72.7B | NOK 208.62 | 1.89% up | 83% up | ||
| 9 | Elanco Animal HealthELAN · Health Care | +1.82% | NOK 127.5B | NOK 255.16 | 1.82% up | 20% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | +1.80% | NOK 47.8B | NOK 274.84 | 1.80% up | 20% down | ||
| 11 | CytokineticsCYTK · Health Care | +1.78% | NOK 71B | NOK 509.64 | 1.78% up | 20% down | ||
| 12 | Oruka TherapeuticsORKA · Health Care | +1.75% | NOK 64.4B | NOK 950.15 | 1.75% up | 241% up | ||
| 13 | Arrowhead PharmaceuticalsARWR · Health Care | +1.65% | NOK 59.9B | NOK 423.65 | 1.65% up | 10% up | ||
| 14 | Ionis PharmaceuticalsIONS · Health Care | +1.59% | NOK 44.2B | NOK 265.53 | 1.59% up | 64% down | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +1.58% | NOK 73.6B | NOK 936.58 | 1.58% up | 126% up | ||
| 16 | BioMarin PharmaceuticalBMRN · Health Care | +1.37% | NOK 111.4B | NOK 574.98 | 1.37% up | 11% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | +1.33% | NOK 1.33T | NOK 5,247.57 | 1.33% up | 27% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | +1.25% | NOK 146.8B | NOK 753.84 | 1.25% up | 17% up | ||
| 19 | ViatrisVTRS · Health Care | +1.20% | NOK 230B | NOK 200.63 | 1.20% up | 96% up | ||
| 20 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.18% | NOK 121B | NOK 145.17 | 1.18% up | 5% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | +1.14% | NOK 48B | NOK 852.82 | 1.14% up | 113% up | ||
| 22 | Roivant SciencesROIV · Health Care | +1.11% | NOK 274.9B | NOK 379.44 | 1.11% up | 90% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | +1.05% | NOK 79.7B | NOK 1,221.25 | 1.05% up | 46% up | ||
| 24 | VeradermicsMANE · Health Care | +0.94% | NOK 51.9B | NOK 1,229.45 | 0.94% up | 233% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | +0.88% | NOK 151.1B | NOK 2,354.14 | 0.88% up | 37% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | +0.87% | NOK 57.5B | NOK 2,873.23 | 0.87% up | 43% up | ||
| 27 | Teva Pharmaceutical IndustriesTEVA · Health Care | +0.59% | NOK 484.9B | NOK 415.60 | 0.59% up | 74% up | ||
| 28 | Definium TherapeuticsDFTX · Health Care | +0.56% | NOK 39.2B | NOK 286.42 | 0.56% up | 169% up | ||
| 29 | PTC TherapeuticsPTCT · Health Care | +0.43% | NOK 49.1B | NOK 587.68 | 0.43% up | 20% down | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +0.42% | NOK 964.5B | NOK 9,323.90 | 0.42% up | 36% up | ||
| 31 | ZoetisZTS · Health Care | +0.31% | NOK 329.9B | NOK 811.81 | 0.31% up | 29% down | ||
| 32 | Royalty PharmaRPRX · Health Care | +0.29% | NOK 384B | NOK 667.75 | 0.29% up | 78% up | ||
| 33 | Abbott LaboratoriesABT · Health Care | +0.15% | NOK 1.76T | NOK 1,016.65 | 0.15% up | 17% down | ||
| 34 | Belite BioBLTE · Health Care | +0.14% | NOK 62.2B | NOK 1,531.14 | 0.14% up | 31% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | +0.07% | NOK 58.2B | NOK 892.03 | 0.07% up | 31% up | ||
| 36 | SanofiSNY · Health Care | +0.06% | NOK 1.11T | NOK 461.07 | 0.06% up | 4% down | ||
| 37 | InsmedINSM · Health Care | +0.06% | NOK 259.3B | NOK 1,182.04 | 0.06% up | 40% down | ||
| 38 | Ascendis PharmaASND · Health Care | +0.02% | NOK 172.5B | NOK 2,629.61 | 0.02% up | 28% up | ||
| 39 | Corcept TherapeuticsCORT · Health Care | +0.02% | NOK 74.4B | NOK 679.43 | 0.02% up | 8% down | ||
| 40 | GSKGSK · Health Care | -0.18% | NOK 955.1B | NOK 476.48 | 0.18% down | 6% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | -0.24% | NOK 78.2B | NOK 1,127.80 | 0.24% down | 13% up | ||
| 42 | Alnylam PharmaceuticalsALNY · Health Care | -0.31% | NOK 202.6B | NOK 1,512.47 | 0.31% down | 66% down | ||
| 43 | GrifolsGRFS · Health Care | -0.35% | NOK 56.7B | NOK 83.37 | 0.35% down | 1% up | ||
| 44 | Madrigal PharmaceuticalsMDGL · Health Care | -0.38% | NOK 94.7B | NOK 4,075.53 | 0.38% down | 24% down | ||
| 45 | GenmabGMAB · Health Care | -0.50% | NOK 309B | NOK 501.20 | 0.50% down | 70% up | ||
| 46 | Johnson & JohnsonJNJ · Health Care | -0.56% | NOK 6.47T | NOK 2,686.61 | 0.56% down | 38% up | ||
| 47 | PfizerPFE · Health Care | -0.58% | NOK 1.56T | NOK 274.40 | 0.58% down | 14% up | ||
| 48 | Takeda PharmaceuticalTAK · Health Care | -0.60% | NOK 666.2B | NOK 208.53 | 0.60% down | 54% up | ||
| 49 | AbbVieABBV · Health Care | -0.63% | NOK 4.99T | NOK 2,820.83 | 0.63% down | 26% up | ||
| 50 | United TherapeuticsUTHR · Health Care | -0.63% | NOK 239.6B | NOK 5,626.59 | 0.63% down | 23% up | ||
| 51 | Travere TherapeuticsTVTX · Health Care | -0.64% | NOK 47.2B | NOK 492.21 | 0.64% down | 44% up | ||
| 52 | Axsome TherapeuticsAXSM · Health Care | -0.70% | NOK 68.8B | NOK 1,308.75 | 0.70% down | 7% down | ||
| 53 | Eli LillyLLY · Health Care | -0.98% | NOK 12.1T | NOK 13,588.62 | 0.98% down | 35% up | ||
| 54 | AstraZenecaAZN · Health Care | -1.02% | NOK 2.71T | NOK 1,748.97 | 1.02% down | 2% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | -1.11% | NOK 44.1B | NOK 403.05 | 1.11% down | 88% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | -1.12% | NOK 1.2T | NOK 588.11 | 1.12% down | 34% up | ||
| 57 | NovartisNVS · Health Care | -1.15% | NOK 2.88T | NOK 1,524.93 | 1.15% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | -1.25% | NOK 1.72T | NOK 389.62 | 1.25% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | -1.29% | NOK 3.38T | NOK 1,371.95 | 1.29% down | 51% up | ||
| 60 | BeOne MedicinesONC · Health Care | -1.67% | NOK 450B | NOK 3,939.57 | 1.67% down | 17% up | ||
| 61 | ErascaERAS · Health Care | -2.48% | NOK 46.1B | NOK 131.31 | 2.48% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6944 NOK).
Questions and answers
Which pharmaceuticals rank first by today's price change?
Summit Therapeutics (+5.93%), Spyre Therapeutics (+2.31%) and ABIVAX (+2.27%) are the top three of the 61 pharmaceuticals ranked by today's price change as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by today's price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by today's price change have a combined market value of NOK 49.72T as of 18 Nov 2026, 15:06 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.